Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at a number of other media outlets and wouldn’t recommend the drug coverage at any of them. When not at Filter, she works with drug users in NYC and drug checkers in North Carolina to track hyperlocal supply changes, and cohosts a national stimulant users call with Isaac Jackson.

    White House Meth Plan Still Includes Harm Reduction, Just Not for Meth

    Once the federal government designated methamphetamine an “emerging drug threat” in March 2022, the ...

    Ohio Bans More Nitazenes, Claiming They Cause Deaths on Their Own

    Ohio has temporarily banned nine nitazene analogs as Schedule I controlled substances, making sale ...

    VT Gov. Vetoes Safe Consumption Site Bill. It May Become Law Without Him.

    Vermont Governor Phil Scott (R) has vetoed legislation that would authorize a safe consumption ...

    Amid DEA War on Meth, Cocaine Is at Last a “Traditional Plant-Based Drug”

    The 2020 National Drug Threat Assessment (NDTA) is such a widely cited document partly ...

    Walgreens Rolls Out $34.99 Naloxone, as Generics and OTC Gain Ground

    Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell ...

    The Opioid Settlements Being Paid in Naloxone Don’t Quite Add Up

    Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the ...

    The Delaware Mass Overdose Drugs Aren’t “Naloxone-Resistant”

    On April 30, Delaware State Police (DSP) and the Delaware Department of Health and ...

    FDA Approves Even Higher-Dose Naloxone Nasal Spray, Again

    The Food and Drug Administration has approved a new naloxone nasal spray that contains ...